If the merger of Pfizer’s off-patent drug unit and Mylan is approved, Mylan CEO Heather Bresch could earn more than $37.6 million in severance and vested benefits, according to The Pittsburgh Post ...

One company makes Xanax and Viagra. The other makes the popular EpiPen drug for people with allergies. Now they may be close to merging. One company makes Xanax and Viagra. The other makes the popular ...

First and foremost, Pfizer just confirmed its desire to acquire British pharmaceutical giant AstraZeneca. Pfizer stated that it initially made a bid for AstraZeneca in January, and approached the ...

Pfizer is spinning off a big chunk of the company, culminating a rare tear of major deals aimed at reshaping the drugmaker into a slimmed-down version with faster, more-sustainable growth. The biggest ...

Pfizer will merge its off-patent drug business with generic drugmaker Mylan, a move that would create a lower-priced medication powerhouse, according to The Wall Street Journal. The combined company ...

PITTSBURGH (AP) — Mylan Inc. said Thursday that it is now selling a generic version of Pfizer Inc.’s overactive bladder drug Detrol. The company said it started shipping its generic after receiving ...